Kamada Ltd is a biopharmaceutical company that specializes in the development and commercialization of innovative therapeutics for rare and serious diseases
The company focuses on producing protein-based drugs, particularly in the fields of immunology and respiratory medicine, utilizing its proprietary technology platforms. By developing therapies that address unmet medical needs, Kamada aims to improve the quality of life for patients while advancing healthcare solutions in specialized treatment areas. The company actively engages in partnerships and collaborations to enhance its research and development efforts, striving to bring new and effective treatments to market.
Gainers ParaZero Technologies Ltd. (NASDAQPRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near people using ParaZero safety systems.
Kamada (NASDAQKMDA) reported its Q2 earnings results on Wednesday, August 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Kamada posted an EPS of $-0.09.
Gainers Minerva Surgical, Inc. (NASDAQUTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods.
Companies Reporting Before The Bell • Bank of Nova Scotia (NYSEBNS) is estimated to report quarterly earnings at $1.78 per share on revenue of $8.09 billion.
Companies Reporting Before The Bell • Sportradar Gr (NASDAQSRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
